Quantification of Apixaban's Therapeutic Utility in Prevention of Venous Thromboembolism: Selection of Phase III Trial Dose

The Clinical Utility Index as a Practical Multiattribute Approach to Drug Development Decisions

(2009) B Poland et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Concepts and Challenges in Quantitative Pharmacology and Model-Based Drug Development

(2008) Liping Zhang et al.   AAPS Journal

Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans

(2008) N. Raghavan et al.   DRUG METABOLISM AND DISPOSITION

Leveraging Prior Quantitative Knowledge to Guide Drug Development Decisions and Regulatory Science Recommendations: Impact of FDA Pharmacometrics During 2004-2006

(2008) Yaning Wang et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin

(2008) Takeshi Fuji et al.   JOURNAL OF ORTHOPAEDIC SCIENCE

Venous thromboembolism in elective operations: Balancing the choices

(2008) Motaz Qadan et al.   SURGERY